Actively Recruiting
Shelter HArm Reduction Evaluation
Led by NYU Langone Health · Updated on 2025-09-12
80
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
C
Centers for Disease Control and Prevention
Collaborating Sponsor
AI-Summary
What this Trial Is About
The proposed study will use mixed methods research to examine overdose and other health-related impacts of harm reduction initiatives in NYC homeless shelters.
CONDITIONS
Official Title
Shelter HArm Reduction Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For Aims 1a, 1b, and 2: Records include individuals aged 18 and older who entered NYC single-adult shelters between 2021 and 2026, plus matched comparison groups with active Medicaid coverage during the same years
- For Aim 3 Homeless Services Client group: Adults 18 or older who speak English, have stayed or are staying in a NYC single-adult shelter with HRSP interventions, report past-year drug use, and can provide consent
- For Aim 3 Homeless Services Staff group: Adults 18 or older who speak English, work at a shelter or agency that implemented HRSP interventions, and can provide consent
- For Aim 3 Homeless Services Stakeholder group: Adults 18 or older who speak English, have key insight on HRSP planning or implementation, and can provide consent
You will not qualify if you...
- For Aims 1a, 1b, and 2: Individuals under age 18 are excluded
- For Aim 3: Under 18 years old, currently a prisoner, unable to communicate in English, or unable to give informed consent
- For Aim 3 Homeless Services Client group: Not excluded if they have not stayed at an HRSP shelter or do not report past-year drug use
- For Aim 3 Homeless Services Staff group: Those not employed at a shelter with HRSP interventions are excluded
- Additional targeting or exclusion criteria may be applied to ensure diverse experiences in qualitative interviews
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
B
Bennett Allen, PhD
CONTACT
K
Kelly Doran, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here